Association between inflammation,body mass index,and long-term outcomes in patients after percutaneous coronary intervention:A large cohort study

作     者：Guyu Zeng Deshan Yuan Sida Jia Peizhi Wang Liu Ru Tianyu Li Ce Zhang Xueyan Zhao Song Lei Lijian Gao Jue Chen Yuejin Yang Shubin Qiao Runlin Gao Xu Bo Jinqing Yuan 

作者机构：National Clinical Research Center for Cardiovascular DiseasesState Key Laboratory of Cardiovascular DiseaseFuwai HospitalNational Center for Cardiovascular DiseasesChinese Academy of Medical Science and Peking Union Medical CollegeBeijing 100037China Department of CardiologyFuwai HospitalNational Center for Cardiovascular DiseasesChinese Academy of Medical Science and Peking Union Medical CollegeBeijing 100037China 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2023年第136卷第14期

页      面：1738-1740页

核心收录：

学科分类：1002[医学-临床医学] 10[医学] 

基　　金：supported by grants from the National Clinical Research Center for Cardiovascular Diseases,Fuwai Hospital,Chinese Academy of Medical Sciences(No.NCRC2020013) CAMS Innovation Fund for Medical Sciences(No.2020-12M-C&T-B-049). 

主　　题：prevention coronary patients 

摘      要：To the Editor:Despite optimal secondary prevention treatments,a large proportion of patients with coronary artery disease(CAD)after percutaneous coronary intervention(PCI)are still at a high risk of recurrent cardiovascular events.Inflammation is a well-known component of residual cardiovascular risk and contributes to progression of atherosclerosis,leading to destabilization and rupture of atheroma plaques.^([1])As a downstream protein in the activated inflammatory pathway that mediates the progression of atherosclerosis,high-sensitivity C-reactive protein(hsCRP)is widely used as a biomarker of inflammatory status and predictor of adverse outcomes in the settings of primary and secondary prevention of cardiovascular disease.